Cellumed Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
30,665
20,735
17,731
9,814
21,609
Cost of Goods Sold (COGS) incl. D&A
18,108
16,125
15,185
9,769
13,758
Gross Income
12,557
4,610
2,546
45
7,850
SG&A Expense
11,693
15,976
10,749
15,458
8,423
EBIT
864
11,458
8,288
-
1,056
Unusual Expense
-
691
579
19,601
5,883
Non Operating Income/Expense
1,791
947
231
232
667
Interest Expense
1,586
2,321
2,793
1,955
1,824
Pretax Income
2,435
15,375
11,981
37,493
9,605
Consolidated Net Income
2,435
15,375
11,981
37,493
9,605
Net Income
2,250
14,913
11,345
36,850
8,830
Net Income After Extraordinaries
2,710
14,913
11,345
36,850
8,830
Net Income Available to Common
1,790
14,913
11,345
36,850
8,830
EPS (Basic)
144.00
1,108.00
770.00
2,160.00
484.00
Basic Shares Outstanding
13
13
15
17
18
EPS (Diluted)
143.22
1,108.49
772.04
2,159.17
484.19
Diluted Shares Outstanding
13
13
15
17
18
EBITDA
4,035
8,495
4,681
12,308
2,040
Other Operating Expense
-
92
85
309
483
Non-Operating Interest Income
79
42
14
96
38
Minority Interest Expense
184
462
636
643
775
Equity in Affiliates (Pretax)
-
-
104
543
214

About Cellumed Co.

View Profile
Address
Unit 402, Ace Techno Tower 9-cha
Seoul SL 08589
Korea, Republic Of
Employees -
Website http://www.cellumed.co.kr
Updated 09/14/2018
CELLUMED Co., Ltd. engages in the manufacture and distribution of medical device and biomaterials. Its products include holders for operations, biologics, artificial joints, and others. The company was founded in June 1975 and is headquartered in Seoul, South Korea.